Hikma Pharmaceuticals PLC

Hikma Pharma Reaffirms FY25 Guidance Amid Strong Start

24 Apr 2025 02:54:25 By NASDAQ US Markets

Axsome Settles Patent Litigation With Hikma Related To Sunosi - Quick Facts

05 Mar 2025 06:55:56 By NASDAQ US Markets

Hikma Pharma Inks Exclusive Commercial Deal With Emergent BioSolutions For KLOXXADO Nasal Spray 8 Mg

14 Jan 2025 07:49:06 By NASDAQ US Markets

Hikma Pharma Extends Recall Of Acetaminophen Injection

23 Jul 2024 02:11:57 By NASDAQ US Markets

Hikma Pharma To Acquire Parts Of Xellia Pharma's US Finished Dosage Form Business And Assets

17 Jun 2024 01:45:01 By NASDAQ US Markets

Collegium Pharma Partners With Hikma For Authorized Generics Of Nucynta In US

29 Apr 2024 08:07:49 By NASDAQ US Markets

Hikma Pharma FY Profit Increases

22 Feb 2024 02:52:27 By NASDAQ US Markets

Hikma Pharma Launches Pain Relief Injection COMBOGESIC IV In US

05 Feb 2024 06:48:52 By NASDAQ US Markets

Guardant Health, Hikma To Offer Cancer Screening & Genomic Profiling Tests In Middle East & Africa

08 Jan 2024 02:35:52 By NASDAQ US Markets

Hikma Pharmaceuticals (LSE:HIK) Price Target Increased by 9.63% to 2,311.15

01 Sep 2023 00:51:58 By NASDAQ Stocks

Hikma Pharma H1 Profit Down, Revenues Up; Lifts FY23 Forecast For Generics

03 Aug 2023 02:46:32 By NASDAQ US Markets

Barclays Reiterates Hikma Pharmaceuticals (LSE:HIK) Equal Weight Recommendation

04 May 2023 19:30:46 By NASDAQ Stocks

Hikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1

12 Apr 2023 01:25:53 By NASDAQ US Markets

Hikma Pharma FY22 Results Down, Lifts Dividend; Says Confident Of FY23 Growth; Stock Up

23 Feb 2023 03:10:05 By NASDAQ US Markets

Hikma accuses Amarin of suppressing generic versions of heart pill

22 Feb 2023 16:13:30 By NASDAQ US Markets

Hikma Pharma Launches Authorized Generic Version Of Xyrem In U.S.

03 Jan 2023 02:15:34 By NASDAQ US Markets

Hikma Pharma Says Not Signed Licensing Agreement With Opiant Pharma

29 Apr 2022 22:58:14 By NASDAQ US Markets

U.S. FTC approves Hikma deal for Custopharm with conditions

19 Apr 2022 13:04:52 By NASDAQ US Markets

Hikma Pharma FY21 Profit Down, Lifts Dividend; Stock Down

24 Feb 2022 02:43:25 By NASDAQ US Markets

Hikma To Acquire Teligent's Canadian Assets - Quick Facts

17 Jan 2022 02:32:15 By NASDAQ US Markets